At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Jul 2, 2026 at 17:47 ET
Three top insiders (CEO, CSO, and CMO) at Contineum Therapeutics exercised and sold shares in a coordinated cluster totaling ~$796K in open-market sales on June 30, 2026. The cluster is entirely sell-side with a clear pattern of derivative exercises paired with immediate share sales, indicating a liquidity/vesting-driven event rather than a uniform bearish conviction call. At ~0.14% of the $570M market cap, the total is modest and within routine proportionality, despite the C-suite breadth.
- Three insiders sold 37,186 shares in open-market sales on June 30- July 1, 2026, totaling ~$796K.
- CEO Carmine Stengone sold 10,000 shares ($160K); CSO Daniel Lorrain sold 28,826 shares ($462K); CMO Tim Watkins sold 10,833 shares ($174K).
- Each insider exercised stock options (prices $0-$4.50) immediately prior to or concurrent with the sales, a typical vesting-and-sell pattern.
- Total open-market sales represent ~0.14% of the company's $570M market cap, below the 0.5% threshold for a notable cluster.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access